Please see BOPA’s Environment and Sustainability Position Statement HERE
The Immune-Related Adverse Effects that arise from use of checkpoint inhibitors can be difficult to manage, especially when steroids are not enough. Despite there being guidance about how to manage…
UTIC (Understanding targeted therapies and immunotherapies for cancer) course has been awarded a FIP Seal. This is a joint collaboration between BOPA and ISOPP. The FIP Seal for programmes is…
Here is an important date for your diaries: The 28th British Oncology Pharmacy Association (BOPA) Annual Conference, 3-5 October 2025, ICC Belfast The conference will include an exciting variety…
The BOPA digital subcommittee are looking for new members. The primary purpose of the BOPA digital subcommittee is to promote excellence in the pharmaceutical care of patients by supporting membership…
The 28th BOPA Annual Conference in 2025 will be held at the ICC Belfast on 3-5 October 2025.
Check out the latest information here: Latest Conference 2025 – BOPA
Everything you need to know
